Date | Analyst | Company | Last | Target | Call | Valuation |
08/24/20 | Amfrasers | Jiutian | 0.046 | 0.068 | Outperform | PER8x |
09/07/20 | Amfrasers | Jiutian | 0.05 | 0.068 | Outperform | |
11/04/20 | UOB Kay Hian | Jiutian | 0.098 | 0.16 | Buy | PER5x FY21 |
11/12/20 | UOB Kay Hian | Jiutian | 0.115 | 0.18 | Buy | PER5x FY21 |
11/26/20 | Amfrasers | Jiutian | 0.086 | 0.14 | Not Rated | |
01/18/21 | CIMB | Jiutian | 0.1 | 0.145 | Add | PER5.7x FY22 |
Friday, January 22, 2021
Jiutian - Stock calls
Stock calls for 22 January 2021
Date | Analyst | Company | Last | Target | Call | Valuation |
01/22/21 | Kim Eng | Capitaland Integrated Commercial Trust | 2.3 | 2.55 | Buy | |
01/22/21 | UOB Kay Hian | Capitaland Integrated Commercial Trust | 2.3 | 2.32 | Hold | Buy @ $2.12 |
01/22/21 | CIMB | Capitaland Integrated Commercial Trust | 2.3 | 2.56 | Add | |
01/22/21 | DMG & Partners | Capitaland Integrated Commercial Trust | 2.3 | 2.1 | Neutral | |
01/22/21 | Lim & Tan | Sabana | 0.375 | 0 | Accumulate |
More than 12K Israelis are getting re-inflected after getting Pfizer vaccinations.
Current vaccinations maybe ineffective against new covid variants.
Dr. Fauci has just announced his latest update about the efficacy of the existing vaccinations. Furthermore, South Africa's NICD stated that the new variant was able to escape from our antibodies.
“Furthermore, 501Y.V2 shows substantial or complete escape from neutralising antibodies in COVID-19 convalescent plasma,” researchers with South Africa’s National Institute for Communicable Diseases wrote. Their conclusions, they said, “highlight the prospect of reinfection ... and may foreshadow reduced efficacy of current spike-based vaccines.”
Why did China clamp down on Ant's IPO? - Part 2
Thursday, January 21, 2021
JEP - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
03/04/20 | Phillip | JEP | 0.205 | 0.25 | Buy | PER14x FY20 |
08/21/20 | Phillip | JEP | 0.19 | 0.158 | Reduce | PB1x |
10/27/20 | UOB Kay Hian | JEP | 0.175 | 0.2 | Buy |
Jardine Matheson - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
03/10/20 | CIMB | Jardine Matheson | 50.12 | 52.53 | Hold | Cut from $61.66 |
08/03/20 | CIMB | Jardine Matheson | 40.92 | 48.61 | Add | PB0.78x FY20 |
12/02/20 | CIMB | Jardine Matheson | 54.52 | 54.68 | Hold | PB0.85x |
Japfa - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
01/20/20 | UOB Kay Hian | Japfa | 0.64 | 0.8 | Buy | |
01/31/20 | CIMB | Japfa | 0.56 | 0.69 | Add | |
01/31/20 | Kim Eng | Japfa | 0.56 | 0.72 | Buy | |
03/03/20 | UOB Kay Hian | Japfa | 0.59 | 0.88 | Buy | Sum of parts |
03/04/20 | DBS Vickers | Japfa | 0.575 | 0.84 | Buy | Sum of parts, PER11x |
04/16/20 | CIMB | Japfa | 0.51 | 0.95 | Add | PER12x CY21 |
04/16/20 | UOB Kay Hian | Japfa | 0.51 | 0.9 | Buy | Sum of parts |
04/16/20 | DBS Vickers | Japfa | 0.51 | 0.84 | Buy | |
05/18/20 | UOB Kay Hian | Japfa | 0.635 | 0.98 | Buy | Sum of parts |
05/18/20 | DBS Vickers | Japfa | 0.635 | 0.86 | Buy | Sum of parts, PER10x FY21 |
06/30/20 | DBS Vickers | Japfa | 0.67 | 0.82 | Buy | Sum of parts, PER10.5x FY21 |
08/03/20 | UOB Kay Hian | Japfa | 0.66 | 0.98 | Buy | Sum of parts |
08/03/20 | DBS Vickers | Japfa | 0.66 | 0.82 | Buy | Sum of parts |
08/03/20 | CIMB | Japfa | 0.66 | 0.96 | Add | |
10/13/20 | CIMB | Japfa | 0.65 | 0.96 | Add | |
11/02/20 | UOB Kay Hian | Japfa | 0.645 | 0.98 | Buy | Sum of parts |
11/02/20 | DBS Vickers | Japfa | 0.645 | 1.03 | Buy | sum of parts, PER11.3x FY21 |
12/08/20 | UOB Kay Hian | Japfa | 0.805 | 1 | Buy | Sum of parts |
12/08/20 | DBS Vickers | Japfa | 0.805 | 1.03 | Buy | sum of parts, PER11.3x FY21 |
12/10/20 | CIMB | Japfa | 0.825 | 1 | Add |